Pregabalin In Partial Seizures: An Open-Label, International, Multicenter Add-On Therapy Trial.
Status:
Completed
Trial end date:
2006-05-01
Target enrollment:
Participant gender:
Summary
To assess the clinical improvement (change in seizure frequency), safety and tolerability of
patients with partial seizures following adjunctive therapy of pregabalin BID in addition to
existing standard AEDs.
Phase:
Phase 4
Details
Lead Sponsor:
Pfizer Pfizer's Upjohn has merged with Mylan to form Viatris Inc.